Loading organizations...
§ Private Profile · Mont-saint-guibert, Brabant Wallon, Belgium
Advanced biopharmaceutical company using adipose stem cells for therapies.
Novadip Biosciences has raised $77.2M across 3 funding rounds.
Novadip Biosciences has raised $77.2M in total across 3 funding rounds.
Novadip Biosciences has raised $77.2M in total across 3 funding rounds.
Novadip Biosciences's investors include Olivier van der Rest, Pierre Drion, CR-CP Life Science Fund, Fund+, InvestSud, SRIW, VIVES Louvain Technology Fund, Jason Zhou, Invest.BW, Franssen Christina, Epim 'e'de, Integral Venture Partners.
Novadip Biosciences has raised $77.2M across 3 funding rounds. Most recently, it raised $23.6M Series B in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 3, 2022 | $23.6M Series B | — | Olivier VAN DER Rest, Pierre Drion, CR CP Life Science Fund, Fund+, Investsud, Sriw, Vives Louvain Technology Fund | Announced |
| Oct 28, 2021 | $22.1M Series B | Jason Zhou | Fund+, Invest.bw, Investsud, Franssen Christina, Vives Louvain Technology Fund | Announced |
| Sep 10, 2015 | $31.5M Series A | — | Epim 'e'de, Fund+, Integral Venture Partners, Sfpi Fpim, Sriw, Startup Capital Ventures, Vives Louvain Technology Fund | Announced |